CA2155532A1 - Steroides pour le traitement des troubles lies a la menopause - Google Patents

Steroides pour le traitement des troubles lies a la menopause

Info

Publication number
CA2155532A1
CA2155532A1 CA002155532A CA2155532A CA2155532A1 CA 2155532 A1 CA2155532 A1 CA 2155532A1 CA 002155532 A CA002155532 A CA 002155532A CA 2155532 A CA2155532 A CA 2155532A CA 2155532 A1 CA2155532 A1 CA 2155532A1
Authority
CA
Canada
Prior art keywords
hydroxy
optionally
alkyl
steroid
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002155532A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Lodewijk Pieter Cornelis Schot
Jane Margretha Lena Van De Werfpieters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo Nobel NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2155532A1 publication Critical patent/CA2155532A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/008—Ketals at position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007—Cyclic thioketals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002155532A 1993-02-08 1994-02-04 Steroides pour le traitement des troubles lies a la menopause Abandoned CA2155532A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93200332.0 1993-02-08
EP93200332 1993-02-08

Publications (1)

Publication Number Publication Date
CA2155532A1 true CA2155532A1 (fr) 1994-08-18

Family

ID=8213615

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002155532A Abandoned CA2155532A1 (fr) 1993-02-08 1994-02-04 Steroides pour le traitement des troubles lies a la menopause

Country Status (15)

Country Link
EP (1) EP0682672A1 (fr)
JP (1) JPH08506116A (fr)
KR (1) KR100364113B1 (fr)
CN (1) CN1046735C (fr)
AU (1) AU4675897A (fr)
BR (1) BR9405825A (fr)
CA (1) CA2155532A1 (fr)
FI (1) FI114101B (fr)
HU (2) HU220615B1 (fr)
NO (1) NO308583B1 (fr)
NZ (1) NZ261581A (fr)
PL (1) PL182901B1 (fr)
RU (1) RU2172740C2 (fr)
WO (1) WO1994018224A1 (fr)
ZA (1) ZA94715B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW403736B (en) * 1997-02-21 2000-09-01 Akzo Nobel Nv Steroid compounds having contraceptive and anti-osteoporosis activity
ID25621A (id) * 1998-03-09 2000-10-19 Akzo Nobel Nv Perlengkapan kontrasepsi baru
MXPA02001831A (es) 1999-09-06 2002-10-23 Akzo Nobel Nv Esteroides estrogenicos no aromaticos con un sustituyente de hidrocarburo en posicion 11.
AU8201601A (en) 2000-07-28 2002-02-13 Akzo Nobel Nv 16alpha-methyl or ethyl substituted estrogens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
ES2881336T3 (es) * 2016-03-03 2021-11-29 Crystal Pharma Sau Procedimiento y nuevos productos intermedios para la preparación de 11-metilen-esteroides

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325520A (en) * 1965-12-08 1967-06-13 Searle & Co (optionally 17-hydrocarbon-substituted) 11, 13beta-dialkylgon-4-en-3-ones and esters corresponding
US3465010A (en) * 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
NL175063C (nl) * 1972-12-09 1984-09-17 Akzo Nv Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten.
FI54128C (fi) * 1972-12-09 1978-10-10 Akzo Nv Foerfarande foer framstaellning av nya 11,11-alkylidensteroider ur oestran- och 19-norpregnanserien med foerbaettrad hormonell verkan
NL7317358A (nl) * 1973-12-19 1975-06-23 Akzo Nv Nieuwe 11(beta)-alkylsteroiden van de oestraanreeks.
NL7701384A (nl) * 1977-02-10 1978-08-14 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de oestraanreeks.
AU532512B2 (en) * 1979-09-07 1983-10-06 Upjohn and Horton Anti-allergenic compounds for bone mineral resorption
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU572589B2 (en) * 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
NL8502571A (nl) * 1985-09-20 1987-04-16 Akzo Nv Steroiden met immunomodulerende eigenschappen.
DE3702383A1 (de) * 1987-01-23 1988-08-04 Schering Ag 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
DK0461290T3 (da) * 1990-06-14 1994-02-21 Henning Berlin Gmbh Væskefyldte stikkapsler
AU8166191A (en) * 1990-08-10 1992-02-13 Ortho Pharmaceutical Corporation Method for treatment of bone wasting diseases

Also Published As

Publication number Publication date
HU0102320D0 (en) 2001-08-28
NO953089L (no) 1995-10-06
RU2172740C2 (ru) 2001-08-27
WO1994018224A1 (fr) 1994-08-18
HUT72971A (en) 1996-06-28
HU220615B1 (hu) 2002-03-28
BR9405825A (pt) 1995-12-05
NZ261581A (en) 1997-06-24
HU9501940D0 (en) 1995-09-28
FI953747A (fi) 1995-09-12
FI114101B (fi) 2004-08-13
PL310125A1 (en) 1995-11-27
FI953747A0 (fi) 1995-08-07
CN1046735C (zh) 1999-11-24
PL182901B1 (pl) 2002-03-29
NO953089D0 (no) 1995-08-07
NO308583B1 (no) 2000-10-02
ZA94715B (en) 1994-10-24
AU4675897A (en) 1998-02-19
JPH08506116A (ja) 1996-07-02
CN1117735A (zh) 1996-02-28
EP0682672A1 (fr) 1995-11-22
AU682170B2 (en) 1997-09-25
AU6039494A (en) 1994-08-29
KR100364113B1 (ko) 2003-04-08

Similar Documents

Publication Publication Date Title
US7148213B2 (en) Antigestagenically active steroids with a fluorinated 17α-alkyl chain
US4814327A (en) 11 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
EP1272504B1 (fr) Estratrienes a substitution 8beta-hydrocarbyle utilises comme oestrogenes a action selective
CA2084431C (fr) Steroides 17-spirofuran-3'-ylidene
WO2000063228A1 (fr) Ent-steroides utilises comme oestrogenes selectivement actifs
FI95711B (fi) Menetelmä terapeuttisesti käyttökelpoisten 4-substituoitujen 17 -(syklopropyylioksi)androst-5-eenijohdannaisten valmistamiseksi, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
US5710144A (en) C-11 substituted steroids for treating menopausal complaints
WO1992004309A1 (fr) Nouvelles progestines 15,16-seco-19-nor
MXPA01008065A (es) Derivados del 16-hidroxiestratrieno empleados como estrogenos selelctivos.
US20060270845A1 (en) 16-Hydroxyestratrienes as selectively active estrogens
CA2155532A1 (fr) Steroides pour le traitement des troubles lies a la menopause
US6037339A (en) C-11 substituted steroids for treating menopausal complaints
ES2241657T3 (es) Esteroides estrogenicos no aromaticos que tienen un sustituyente hidrocarburo en la posicion 11.
RU2147306C1 (ru) 15,15-диалкилстероидные соединения, способ их получения, соединения и способ их получения
AU682170C (en) Steroids for treating menopausal complaints
GB2160873A (en) 11B-(4-Aminophenyl) estra-4,9-dienes
IE67321B1 (en) 14alpha, 17alpha-ethano-16alpha-hydroxy-estratrienes
US3840568A (en) Estratriene derivatives
MXPA99006625A (en) 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead